Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U0RZ
|
||||
Former ID |
DAP000719
|
||||
Drug Name |
Phentermine
|
||||
Synonyms |
Duromine; Fastin; Fentermina; Inoamin; Ionamin; Ionamine; Linyl; Lipopill; Lonamin; Mirapront; Normephentermine; Obenix; Obermine; Omnibex; Ortetamin; Ortetamina; Ortetaminum; Phentercot; Phenterminum; Phentride; Phentrol; Wilpo; Zantryl; Ona Mast; Ortetamine [INN]; Phentermine HCl; Phentermine resin complex; AmbkkkkK744; Phentermine Resin 30; Phentrol 2; Phentrol 3; Phentrol 4; Adipex P (TN); Adipex-P; Alpha-Benzylisopropylamine; Duromine (TN); Fastin (TN); Fentermina [INN-Spanish]; Ionamin (TN); Mirapront (TN); Obenix (TN); Obephen (TN); Obermine (TN); Oby-Trim; Panbesy (TN); Phenterex (TN); Phentermine (TN); Phenterminum [INN-Latin]; Phentremene (TN); Phentrol (TN); Phentromin (TN); Pro-Fast; Redusa (TN); Sinpet (TN); Supremin (TN); Teramine (TN); Trenker (TN); Umine (TN); Weltmine (TN); Zantryl (TN); Alpha,alpha-Dimethylbenzeneethanamine; Alpha,alpha-Dimethylphenethylamine; Anoxine-AM (TN); Obestin-30 (TN); Oby-Trim (TN); Phentermine (USAN/INN); Phentermine [USAN:INN:BAN]; Phenyl-tert-butylamine; Phenyl-tertiary-butylamine; Pro-Fast SA (TN); Alpha,alpha-Dimethyl-beta-phenylethylamine; Alpha.,.alpha.-dimethyl-Benzeneethanamine; (alpha,alpha)-Dimethylphenethylamine; 1,1-Dimethyl-2-phenylethylamine; 1-(2-Methylphenyl)-2-propylamin; 1-(2-Tolyl)-2-propylamine; 2-Amino-2-methyl-1-phenylpropane; 2-Methyl-1-phenyl-2-propanamine; 2-Phenyl-tert-butylamine; 2-methyl-1-phenylpropan-2-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Appetite Depressants
|
||||
Company |
Medeva Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H15N
|
||||
InChI |
InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3
|
||||
InChIKey |
DHHVAGZRUROJKS-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 122-09-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9642, 3222908, 4448495, 7980294, 8152931, 10505791, 15194700, 29223855, 43997956, 46508515, 47207127, 48416420, 49760715, 50004323, 50139243, 50429715, 57322442, 92307866, 103589701, 104101988, 104307379, 108670465, 119523660, 125309124, 126540999, 127734846, 134223805, 134338007, 134339372, 134973544, 137001247, 140204802, 144075901, 160963539, 163138806, 164205807, 170505704, 175266408, 176325847, 178103843, 179095233, 184574182, 184823557, 223787896, 226414425, 243694279, 249924131, 252324490
|
||||
ChEBI ID |
ChEBI:8080
|
||||
SuperDrug ATC ID |
A08AA01
|
||||
SuperDrug CAS ID |
cas=000100925
|
||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [535068] | |
PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
References | |||||
Ref 536710 | Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. | ||||
Ref 542288 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7269). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.